Side-by-side comparison of AI visibility scores, market position, and capabilities
Apixio uses NLP and machine learning to extract structured clinical insights from unstructured medical records, enabling more accurate risk adjustment and quality measurement for health plans.
Apixio's AI platform reads unstructured clinical documentation — physician notes, discharge summaries, operative reports, and scanned records — and extracts coded diagnoses, procedures, and clinical findings at scale using natural language processing and machine learning. Health plans and risk-bearing provider organizations use this extracted data to improve the accuracy of risk adjustment submissions to CMS, ensuring patients' true disease burden is captured in their risk scores.
Adept AI raised $415M to pioneer computer-use AI agents; its core research and agent team moved to Amazon in 2024 in a landmark talent acquisition while the company continues developing ACT-1 for enterprise automation.
Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and executing multi-step workflows in any application. Its ACT-1 model demonstrated the ability to control web browsers and desktop applications through natural language instructions, pioneering the computer-use agent paradigm that Anthropic later commercialized with Claude's computer use feature.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.